Hikma Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Hikma Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14% to $2,875,000,000. The net income raised on $190,000,000 and profit margin reached 7%. Total operating expenses were $1,040,000,000.
Profit Margin
| 2014 | 1.48B | 278M | 18.67% |
|---|---|---|---|
| 2015 | 1.44B | 252M | 17.5% |
| 2016 | 1.95B | 155M | 7.95% |
| 2017 | 1.93B | -843M | -43.54% |
| 2018 | 2.07B | 282M | 13.62% |
| 2019 | 2.20B | 486M | 22.02% |
| 2020 | 2.34B | 431M | 18.41% |
| 2021 | 2.55B | 421M | 16.49% |
| 2022 | 2.51B | 188M | 7.47% |
| 2023 | 2.87B | 190M | 6.61% |
HKMPY Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.87B | 2.51B | 2.55B | 2.34B | 2.20B | 2.07B | 1.93B | 1.95B | 1.44B | 1.48B |
Cost of revenue | 1.46B | 1.27B | 1.25B | 1.14B | 1.05B | 1.02B | 969M | 964M | 622M | 638M |
Gross profit | 1.40B | 1.23B | 1.30B | 1.20B | 1.14B | 1.05B | 967M | 986M | 818M | 851M |
Operating exp. | ||||||||||
Research and development | 149M | 144M | 143M | 137M | 150M | 147M | 115M | 150M | 36M | 55M |
Selling and marketing | 0 | 0 | 0 | 0 | 494M | 224M | 188M | 184M | 156M | 171M |
Total operating expenses | 1.04B | 756M | 742M | 687M | 655M | 690M | 635M | 611M | 401M | 449M |
Operating income | 367M | 507M | 582M | 579M | 493M | 371M | -747M | 302M | 381M | 402M |
Other income (expenses), net | -86M | -274M | -38M | -21M | -2M | -78M | 9M | -92M | -63M | -40M |
Income before tax | 281M | 233M | 544M | 558M | 491M | 293M | -738M | 210M | 318M | 362M |
Income tax expense | 89M | 42M | 124M | 128M | 4M | 8M | 101M | 52M | 64M | 80M |
Net income | 190M | 188M | 421M | 431M | 486M | 282M | -843M | 155M | 252M | 278M |
Earnings per share | ||||||||||
Basic EPS | 1.72 | 1.68 | 3.65 | 3.65 | 4.02 | 2.34 | -7.02 | 1.33 | 2.53 | 2.81 |
Diluted EPS | 1.71 | 1.67 | 3.61 | 3.62 | 4 | 2.33 | -7 | 1.32 | 2.51 | 2.78 |